@ARTICLE{
author={Verschraegen Claire,Andric Zoran G,Moiseenko Fedor,Makharadze Tamta,Shevnya Sergii,Oleksiienko Alona,Ruiz Eduardo Yanez,Kim SungHyun,Ahn KeumYoung,Park TaeHong,Park Sijin,Ju Hana,Ohe Yuichiro},
year={2022},
title={Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
journal={BIODRUGS},
volume={36},
number={6},
pages={749-760},
document_type={Article},
}